Dana-Farber/Brigham and Women's Cancer Care Collaborative
Learn more about the collaborative. We’re here to help. If you have questions or need assistance, call 203.276.4452.
About the Collaborative
The Bennett Cancer Center is proud to be a member of the Dana-Farber/Brigham and Women’s Cancer Care Collaborative (DF/BWCC), providing our staff and patients access to the latest and most effective, evidence-based best practices and standards in cancer treatment and research. One of the nation’s “Best Hospitals for Cancer” (according to U.S. News & World Report), DF/BWCC further enhances the quality, value and efficiency of medical oncology and radiation oncology services at Stamford Health.
In 2016, Stamford Health joined the Dana-Farber/Brigham and Women's Cancer Care Collaborative which includes a select group of hospitals that have demonstrated a commitment to excellence by meeting a wide range of cancer care standards and best practices. Dana-Farber and Brigham and Women’s clinicians and other specialists conducted an extensive and rigorous review of the Bennett Cancer Center’s outpatient adult medical and radiation oncology practices and procedures, including:
- Patient safety protocols
- Nursing and pharmacy practices
- Chemotherapy administration
- Information systems
As of the fall 2020, Stamford Health and Dana-Farber Brigham and Women’s Cancer Center are pioneering a deeper relationship
The expanded relationship includes a mutual commitment to offering the very best in cancer care in a healing environment without having to travel. As a patient, you can expect the following:
- Access to more resources than ever before through DF/BWCCC.
- Expanded options for treatment based on the latest research available through the collaborative.
- Additional clinical trials available to you, if you qualify.
Frequently Asked Questions About the Collaborative
1. In brief, what does this mean for the Bennett Cancer Center’s model of care?
This relationship is a validation of the high quality of cancer care already provided by the Bennett Cancer Center. In addition, it means that the Bennett Cancer Center will have access to the treatment protocols utilized by Dana-Farber Cancer Institute and Brigham and Women’s Hospital.
2. Are more opportunities going to be available to patients for newer or more clinical trials?
The goal is to open more promising studies that would otherwise not be available locally. In addition, there will be expedited access for patients who may qualify for clinical trials open in Boston.
3. Does this mean I’ll need to be sent to Boston to receive additional treatment?
No, this does not mean that you will need to travel to Boston. It does mean that you can receive second opinions from world- renowned experts at Dana-Farber Cancer Institute and Brigham and Women’s Hospital through the collaborative cancer conferences that the BCC oncologists participate in with their colleagues in Boston.
Also, your oncologist may work with a physician at Dana-Farber Cancer Institute and/or Brigham and Women’s Hospital to obtain a second opinion virtually. However, if there are very promising studies or treatments only available at Dana-Farber Cancer Institute or Brigham and Women’s Hospital and not available locally, then we may recommend going to Boston. Our participation in the DF/BWCCC will ensure you are seen in a timely manner.
4. How do I find out if I, personally, can benefit from this collaborative?
You can ask your oncologist about a second opinion. Because of the collaboration, we have much easier and faster access to the leaders in the field to ensure that we have considered all treatment options.
5. What are some of the top scenarios in which one can directly benefit from this collaborative?
Sometimes in complicated cases, it can be confusing and time consuming to see different oncologists. We can present cases to the experts at Dana-Farber Cancer Institute and Brigham and Women’s Hospital either at the collaborative cancer case conferences or through direct communication with individual physicians. The experts will collaborate to recommend one treatment plan, which can help you feel more confident in the care you will receive, giving you peace of mind.